VOLITIONRX LTD (VNRX) 8-K filings
- Ticker
- VNRX (NYSE)
- SEC CIK
- 93314
- Industry (SIC)
- 2835 In Vitro & In Vivo Diagnostic Substances
- Incorporated in
- DE
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-12 16:15 | 8-K | 2.02 Earnings release | Details |
| 2026-11-12 08:30 | 8-K | 5.02 Executive or director change | Details |
| 2026-10-27 17:00 | 8-K | 1.01 Material agreement8.01 Other events | Details |